AMPLATZER™ LAA Occluder Post Approval Study (PAS)


Phase N/A Results N/A

Summary of Purpose

The AMPLATZER LAA Occluder is a transcatheter, self-expanding nitinol device intended for use in preventing thrombus embolization from the LAA. The purpose of this study is to compile real world outcome data on the use of AMPLATZER LAA Occluder in subjects with non-valvular atrial fibrillation (NVAF)

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 November 2016.

1 Oct 2016 6 Oct 2016 1 Oct 2023 Unavailable 1 Oct 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available